Close Menu
Daily Guardian
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
What's On

NVIDIA Releases Vera Rubin DSX AI Factory Reference Design and Omniverse DSX Digital Twin Blueprint With Broad Industry Support

March 16, 2026

Merlin and Inflection Point Acquisition Corp. IV Announce Closing of Business Combination

March 16, 2026

Giant order: Volvo lands major 400-truck deal

March 16, 2026

Alberta reviewing plan on forcing oil companies to pay outstanding municipal taxes

March 16, 2026

NVIDIA Launches Space Computing, Rocketing AI Into Orbit

March 16, 2026
Facebook X (Twitter) Instagram
Finance Pro
Facebook X (Twitter) Instagram
Daily Guardian
Subscribe
  • Home
  • News
  • Politics
  • Business
  • Entertainment
  • Lifestyle
  • Health
  • Sports
  • Technology
  • Climate
  • Auto
  • Travel
  • Web Stories
Daily Guardian
Home » $4.396 Bn Glycomics Market Trends, Opportunities, and Forecasts, 2030 – Rising Chronic and Infectious Disease Burden and Demand for Advanced Diagnostic and Therapeutic Tools
Press Release

$4.396 Bn Glycomics Market Trends, Opportunities, and Forecasts, 2030 – Rising Chronic and Infectious Disease Burden and Demand for Advanced Diagnostic and Therapeutic Tools

By News RoomDecember 2, 20253 Mins Read
.396 Bn Glycomics Market Trends, Opportunities, and Forecasts, 2030 – Rising Chronic and Infectious Disease Burden and Demand for Advanced Diagnostic and Therapeutic Tools
Share
Facebook Twitter LinkedIn Pinterest Email

Dublin, Dec. 02, 2025 (GLOBE NEWSWIRE) — The “Glycomics Market – Global Industry Size, Share, Trends, Opportunity, and Forecast, 2020-2030F” report has been added to ResearchAndMarkets.com’s offering.

The Global Glycomics Market, valued at USD 1.94 Billion in 2024, is projected to experience a CAGR of 14.59% to reach USD 4.39 Billion by 2030

Glycomics is defined as the comprehensive study of glycomes, encompassing all glycan structures, whether free or complex molecules, within an organism or cell, to understand their genetic, physiological, and pathological aspects. The global glycomics market growth is significantly driven by the increasing prevalence of chronic diseases, necessitating advanced diagnostic and therapeutic tools.

The escalating global burden of chronic and infectious diseases significantly propels the glycomics market, as glycans are integral to disease pathology, immune modulation, and pathogen interactions, necessitating advanced diagnostic and therapeutic tools. Conditions such as cancer, autoimmune disorders, and metabolic diseases, including diabetes, demand sophisticated glycomics-based solutions for early detection and targeted interventions.

According to the International Diabetes Federation, in 2023, an estimated 537 million adults aged 20-79 years were living with diabetes worldwide, underscoring the substantial patient population requiring improved approaches to disease management. This pervasive disease prevalence directly stimulates demand for glycomics research and applications, fostering the discovery of novel glycan biomarkers and the development of targeted glycan-based drugs and vaccines to address critical unmet medical needs.

Key Market Challenges

A significant challenge impeding market expansion stems from the inherent structural complexity and vast diversity of glycan structures. This biological intricacy profoundly complicates comprehensive analysis and standardization efforts essential for advancing glycomics applications. The extensive range of glycan configurations and their context-dependent roles necessitate highly specialized and often costly analytical techniques, leading to prolonged research and development cycles.

Key Market Trends

The integration of artificial intelligence and machine learning in glycan data analysis represents a transformative trend, enabling researchers to process and interpret the vast, complex datasets generated from glycomics studies with greater efficiency and accuracy. These technologies are crucial for identifying patterns and correlations in glycan structures that were previously challenging to detect.

For example, according to GlycanML: A Multi-Task and Multi-Structure Benchmark for Glycan Machine Learning, published on arXiv in May 2024, machine learning models are being developed to predict glycan taxonomy, immunogenicity, glycosylation types, and protein-glycan interactions across diverse tasks. This analytical capability accelerates biomarker discovery and therapeutic development by translating complex glycomics information into actionable insights.

Key Attributes:

Report Attribute Details
No. of Pages 186
Forecast Period 2024 – 2030
Estimated Market Value (USD) in 2024 $1.94 Billion
Forecasted Market Value (USD) by 2030 $4.39 Billion
Compound Annual Growth Rate 14.5%
Regions Covered Global


Report Scope:

Key Market Players Profiled:

  • Thermo Fisher Scientific, Inc.
  • Merck KgaA
  • Agilent Technologies Inc.
  • Bruker Corporation
  • New England Biolabs Inc.
  • Shimadzu Corporation
  • Waters Corporation
  • Takara Bio USA Inc
  • Asparia Glycomics
  • RayBiotech Life, Inc.

By Product:

  • Enzymes
  • Kits
  • Reagents
  • Instruments

By Application:

  • Drug Discovery & Development
  • Diagnostics
  • Others

By End Use:

  • Academic & Research Institutes
  • Pharmaceutical & Biotechnology Companies
  • Biopharmaceutical Companies
  • CROs

By Region:

  • North America
  • Europe
  • Asia-Pacific
  • South America
  • Middle East & Africa

For more information about this report visit https://www.researchandmarkets.com/r/qinj1t

About ResearchAndMarkets.com
ResearchAndMarkets.com is the world’s leading source for international market research reports and market data. We provide you with the latest data on international and regional markets, key industries, the top companies, new products and the latest trends.


Share. Facebook Twitter Pinterest LinkedIn Tumblr Email

Keep Reading

NVIDIA Releases Vera Rubin DSX AI Factory Reference Design and Omniverse DSX Digital Twin Blueprint With Broad Industry Support

Merlin and Inflection Point Acquisition Corp. IV Announce Closing of Business Combination

Giant order: Volvo lands major 400-truck deal

NVIDIA Launches Space Computing, Rocketing AI Into Orbit

NVIDIA Announces NemoClaw for the OpenClaw Community

NVIDIA Expands Open Model Families to Power the Next Wave of Agentic, Physical and Healthcare AI

NVIDIA Launches Nemotron Coalition of Leading Global AI Labs to Advance Open Frontier Models

NVIDIA Ignites the Next Industrial Revolution in Knowledge Work With Open Agent Development Platform

BYD, Geely, Isuzu and Nissan Adopt NVIDIA DRIVE Hyperion for Level 4 Vehicles

Editors Picks

Merlin and Inflection Point Acquisition Corp. IV Announce Closing of Business Combination

March 16, 2026

Giant order: Volvo lands major 400-truck deal

March 16, 2026

Alberta reviewing plan on forcing oil companies to pay outstanding municipal taxes

March 16, 2026

NVIDIA Launches Space Computing, Rocketing AI Into Orbit

March 16, 2026

Latest News

NVIDIA Announces NemoClaw for the OpenClaw Community

March 16, 2026

NVIDIA Expands Open Model Families to Power the Next Wave of Agentic, Physical and Healthcare AI

March 16, 2026

Ecovacs’ Deebot X8 and X9 Pro Omni robovacs are nearly 50 percent off

March 16, 2026
Facebook X (Twitter) Pinterest TikTok Instagram
© 2026 Daily Guardian Canada. All Rights Reserved.
  • Privacy Policy
  • Terms
  • Advertise
  • Contact

Type above and press Enter to search. Press Esc to cancel.

Go to mobile version